Diabetes Dialogue: Latest Updates on Semaglutide
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives! Key Timestamps and Highlights 01:25 – Discussion of the SOUL trial for oral semaglutide and cardiovascular events. 00:06:39 – Discussion of the higher dose 25 mg and 50mg oral semaglutide trials for obesity. 00:10:16 – Semaglutide and osteoarthritis. 00:18:47 – Semaglutide in patients with kidney disease […]
